EA011400B1 - Лекарственные формы модафинила с модифицированным высвобождением - Google Patents
Лекарственные формы модафинила с модифицированным высвобождением Download PDFInfo
- Publication number
- EA011400B1 EA011400B1 EA200600590A EA200600590A EA011400B1 EA 011400 B1 EA011400 B1 EA 011400B1 EA 200600590 A EA200600590 A EA 200600590A EA 200600590 A EA200600590 A EA 200600590A EA 011400 B1 EA011400 B1 EA 011400B1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- modafinil
- dosage form
- release
- form according
- modafinil compound
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A61K9/2846—Poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Urology & Nephrology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US50402803P | 2003-09-18 | 2003-09-18 | |
| US10/944,528 US8153159B2 (en) | 2003-09-18 | 2004-09-17 | Modafinil modified release pharmaceutical compositions |
| PCT/US2004/030815 WO2005027890A1 (en) | 2003-09-18 | 2004-09-20 | Modafinil modified release pharmaceutical compositions |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EA200600590A1 EA200600590A1 (ru) | 2006-08-25 |
| EA011400B1 true EA011400B1 (ru) | 2009-02-27 |
Family
ID=34381093
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EA200600590A EA011400B1 (ru) | 2003-09-18 | 2004-09-20 | Лекарственные формы модафинила с модифицированным высвобождением |
Country Status (20)
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL142896A0 (en) * | 1998-11-02 | 2002-04-21 | Elan Corp Plc | Multiparticulate modified release composition |
| ATE483455T1 (de) | 2004-05-28 | 2010-10-15 | Transform Pharmaceuticals Inc | Mischkristalle sowie sie enthaltende pharmazeutische zusammensetzungen |
| US20060121112A1 (en) * | 2004-12-08 | 2006-06-08 | Elan Corporation, Plc | Topiramate pharmaceutical composition |
| US20100136106A1 (en) * | 2005-06-08 | 2010-06-03 | Gary Liversidge | Modified Release Famciclovir Compositions |
| BRPI0707736A2 (pt) | 2006-02-13 | 2011-05-10 | Vanda Pharmaceuticals Inc | formulaÇÕes de imidazolilalquil-piridinas de dosagem estÁvel |
| JP2009543803A (ja) * | 2006-07-12 | 2009-12-10 | エラン・ファルマ・インターナショナル・リミテッド | モダフィニルのナノ粒子製剤 |
| DE102006035549A1 (de) | 2006-07-27 | 2008-01-31 | Evonik Röhm Gmbh | Arzneiform mit mindestens zweischichtiger Trennschicht |
| US20090082461A1 (en) * | 2007-09-25 | 2009-03-26 | Protia, Llc | Deuterium-enriched modafinil |
| JP5250285B2 (ja) * | 2008-03-26 | 2013-07-31 | 富士フイルム株式会社 | 経口物用被覆材、可食性容器およびそれらを用いた経口物 |
| WO2010012407A1 (en) * | 2008-07-29 | 2010-02-04 | Ashland Licensing And Intellectual Property Llc. | Modified additives for suppressing dust formation |
| JP2013530220A (ja) * | 2010-07-06 | 2013-07-25 | ナビファーム.カンパニー リミテッド | ダポキセチンを含む時間差徐放性経口投与型の薬学的組成物 |
| US8999393B1 (en) * | 2013-01-09 | 2015-04-07 | Edgemont Pharmaceuticals Llc | Sustained release formulations of lorazepam |
| CA2947528C (en) | 2014-05-01 | 2023-09-05 | Sun Pharmaceutical Industries Limited | Extended release suspension compositions |
| WO2017058869A1 (en) | 2015-09-29 | 2017-04-06 | Acorda Therapeutics, Inc. | Sustained release compositions of 4-aminopyridine |
| MY200542A (en) * | 2017-07-10 | 2024-01-02 | Takeda Pharmaceuticals Co | Preparation comprising vonoprazan |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20010038863A1 (en) * | 2000-02-23 | 2001-11-08 | Christof Jaenicke | Pharmaceutical with predetermined activity profile |
| WO2002096401A1 (en) * | 2001-05-25 | 2002-12-05 | Cephalon, Inc. | Solid pharmaceutical formulations comprising modafinil |
| WO2004024134A1 (en) * | 2002-09-13 | 2004-03-25 | Cephalon, Inc. | Pharmaceutical formulations of modafinil |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5534263A (en) * | 1995-02-24 | 1996-07-09 | Alza Corporation | Active agent dosage form comprising a matrix and at least two insoluble bands |
| US6346548B1 (en) * | 1999-08-16 | 2002-02-12 | Cephalon, Inc. | Compositions including modafinil for treatment of attention deficit hyperactivity disorder and multiple sclerosis fatigue |
| US6627223B2 (en) * | 2000-02-11 | 2003-09-30 | Eurand Pharmaceuticals Ltd. | Timed pulsatile drug delivery systems |
| US6492396B2 (en) | 2000-05-16 | 2002-12-10 | Cephalon, Inc. | Substituted thioacetamides |
| US6489363B2 (en) * | 2000-10-11 | 2002-12-03 | Cephalon, Inc. | Pharmaceutical solutions of modafinil compounds |
| US6344215B1 (en) | 2000-10-27 | 2002-02-05 | Eurand America, Inc. | Methylphenidate modified release formulations |
| US7141555B2 (en) | 2000-12-19 | 2006-11-28 | Cephalon, Inc. | Modafinil compound and cyclodextrin mixtures |
| GB0117618D0 (en) | 2001-07-19 | 2001-09-12 | Phoqus Ltd | Pharmaceutical dosage form |
| US7229644B2 (en) * | 2002-05-23 | 2007-06-12 | Cephalon, Inc. | Pharmaceutical formulations of modafinil |
-
2004
- 2004-09-17 AR ARP040103336A patent/AR046410A1/es unknown
- 2004-09-17 US US10/944,528 patent/US8153159B2/en not_active Expired - Fee Related
- 2004-09-20 AU AU2004274017A patent/AU2004274017B2/en not_active Ceased
- 2004-09-20 WO PCT/US2004/030815 patent/WO2005027890A1/en not_active Ceased
- 2004-09-20 MY MYPI20043844A patent/MY144755A/en unknown
- 2004-09-20 KR KR1020067005361A patent/KR20060117910A/ko not_active Ceased
- 2004-09-20 ES ES04788862T patent/ES2336215T3/es not_active Expired - Lifetime
- 2004-09-20 EA EA200600590A patent/EA011400B1/ru not_active IP Right Cessation
- 2004-09-20 DE DE602004024220T patent/DE602004024220D1/de not_active Expired - Lifetime
- 2004-09-20 TW TW093128394A patent/TWI344840B/zh not_active IP Right Cessation
- 2004-09-20 BR BRPI0414299-3A patent/BRPI0414299A/pt not_active IP Right Cessation
- 2004-09-20 MX MXPA06003125A patent/MXPA06003125A/es active IP Right Grant
- 2004-09-20 EP EP04788862A patent/EP1670447B1/en not_active Expired - Lifetime
- 2004-09-20 NZ NZ545573A patent/NZ545573A/en not_active IP Right Cessation
- 2004-09-20 CA CA2536666A patent/CA2536666C/en not_active Expired - Fee Related
- 2004-09-20 JP JP2006527123A patent/JP5138932B2/ja not_active Expired - Fee Related
- 2004-09-20 AT AT04788862T patent/ATE448780T1/de not_active IP Right Cessation
-
2006
- 2006-02-14 IL IL173738A patent/IL173738A/en not_active IP Right Cessation
- 2006-02-23 IS IS8327A patent/IS2787B/is unknown
- 2006-02-28 NO NO20060964A patent/NO20060964L/no not_active Application Discontinuation
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20010038863A1 (en) * | 2000-02-23 | 2001-11-08 | Christof Jaenicke | Pharmaceutical with predetermined activity profile |
| WO2002096401A1 (en) * | 2001-05-25 | 2002-12-05 | Cephalon, Inc. | Solid pharmaceutical formulations comprising modafinil |
| WO2004024134A1 (en) * | 2002-09-13 | 2004-03-25 | Cephalon, Inc. | Pharmaceutical formulations of modafinil |
Also Published As
| Publication number | Publication date |
|---|---|
| MY144755A (en) | 2011-10-31 |
| EA200600590A1 (ru) | 2006-08-25 |
| TWI344840B (en) | 2011-07-11 |
| NO20060964L (no) | 2006-04-18 |
| US8153159B2 (en) | 2012-04-10 |
| IS8327A (is) | 2006-02-23 |
| ES2336215T3 (es) | 2010-04-09 |
| CA2536666A1 (en) | 2005-03-31 |
| KR20060117910A (ko) | 2006-11-17 |
| EP1670447B1 (en) | 2009-11-18 |
| AR046410A1 (es) | 2005-12-07 |
| AU2004274017A1 (en) | 2005-03-31 |
| ATE448780T1 (de) | 2009-12-15 |
| NZ545573A (en) | 2010-02-26 |
| US20050095294A1 (en) | 2005-05-05 |
| WO2005027890A1 (en) | 2005-03-31 |
| JP5138932B2 (ja) | 2013-02-06 |
| DE602004024220D1 (de) | 2009-12-31 |
| IL173738A0 (en) | 2006-07-05 |
| HK1089697A1 (en) | 2006-12-08 |
| BRPI0414299A (pt) | 2006-11-14 |
| EP1670447A1 (en) | 2006-06-21 |
| IS2787B (is) | 2012-06-15 |
| AU2004274017B2 (en) | 2010-07-08 |
| IL173738A (en) | 2012-07-31 |
| TW200520748A (en) | 2005-07-01 |
| CA2536666C (en) | 2012-06-19 |
| JP2007518696A (ja) | 2007-07-12 |
| MXPA06003125A (es) | 2006-06-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101522176B (zh) | 氟班色林的制剂及其制备方法 | |
| KR101612931B1 (ko) | 1일 1회 투여로 약리학적 임상 효과를 제공하는 모사프리드 서방성 제제 | |
| US9532954B2 (en) | Controlled release and taste masking oral pharmaceutical compositions | |
| KR101752014B1 (ko) | 고용량 및 저용량 약물들의 조합을 포함하는 구강붕해정 조성물 | |
| JP5745556B2 (ja) | ネラメキサン放出調節マトリックス錠 | |
| RU2376988C2 (ru) | Фармацевтические композиции замедленного высвобождения, содержащие аплиндор и его производные | |
| JP2013501810A (ja) | 医薬組成物 | |
| CN101784266B (zh) | 氢溴酸安非他酮以及治疗的应用 | |
| CN1607947A (zh) | 包含3-(3-二甲基氨基-1-乙基-2-甲基-丙基)苯酚并能提供活性成分的延迟释放的药物 | |
| KR20110117216A (ko) | R-바클로펜 전구약물의 서방형 경구 투약 형태 | |
| CN102036656A (zh) | 含有蜡的缓释制剂 | |
| JP2009502987A (ja) | カルビドパとレボドパを含有する延長放出型固形医薬組成物 | |
| AU2004274017B2 (en) | Modafinil modified release pharmaceutical compositions | |
| WO2007054976A2 (en) | Lipid based controlled release pharmaceutical composition | |
| EP2533767A1 (en) | Pharmaceutical compositions comprising a combination of metformin and sitagliptin | |
| NO20121414A1 (no) | Farmasoytiske sammensetninger omfattende hydromorfon og nalokson | |
| KR20140045925A (ko) | 선택적 세로토닌 재흡수 억제제의 방출조절형 약제학적 조성물 | |
| KR20080013927A (ko) | 벤라팍스의 하나 이상 형태의 개질 방출 조성물 | |
| WO2015063670A1 (en) | Solid oral modified-release composition comprising oxcarbazepine or a pharmaceutically acceptable salt thereof | |
| CN101031290B (zh) | 改良释放的莫达非尼药物组合物 | |
| KR20170001545A (ko) | 모사프리드 서방성 제제 및 모사프리드와 라베프라졸의 복합제제 | |
| HK1089697B (en) | Modafinil modified release pharmaceutical compositions | |
| HK1142811B (en) | Bupropion hydrobromide and therapeutic applications |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): AM AZ BY KZ KG MD TJ TM |
|
| MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): RU |